Provided by Tiger Trade Technology Pte. Ltd.

LMP Capital and Income Fund Inc

14.72
+0.04000.27%
Post-market: 14.720.00000.00%17:46 EDT
Volume:111.24K
Turnover:1.64M
Market Cap:336.46M
PE:5.24
High:14.81
Open:14.67
Low:14.63
Close:14.68
52wk High:16.18
52wk Low:13.79
Shares:22.86M
Float Shares:22.86M
Volume Ratio:1.67
T/O Rate:0.49%
Dividend:1.44
Dividend Rate:9.79%
EPS(TTM):2.81
EPS(LYR):-0.0358
ROE:19.14%
ROA:1.15%
PB:0.85
PE(LYR):-411.10

Loading ...

Fulcrum discontinues pociredir program in SCD, initiates strategic review

TIPRANKS
·
Jun 02

Press Release: ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026

Dow Jones
·
May 14

Press Release: Franklin Templeton Announces Distributions for Certain Closed-End Funds Pursuant to their Managed Distribution Policy for the Months of June, July and August 2026

Dow Jones
·
May 14

Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026

GlobeNewswire
·
May 12

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 09

Beam Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates

GlobeNewswire
·
May 07

SeaStar Medical to Report First Quarter Financial Results on May 13, 2026

GlobeNewswire
·
May 06

Press Release: Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 05

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 05

Press Release: Franklin Templeton Announces Availability of 19(a) Notices for Certain Closed-End Funds

Dow Jones
·
Apr 30

LMP Capital and Income Fund elects Agdern, Kamerick, Mason as Class III directors

Reuters
·
Apr 29

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026

GlobeNewswire
·
Apr 27

Press Release: Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors

Dow Jones
·
Apr 27

Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)

GlobeNewswire
·
Apr 23

LMP Capital and Income Fund updates portfolio management team effective May 1, 2026

Reuters
·
Apr 17